Last Price
Where today's price sits in its 52-week range
Libra Infusions Limited ওষুধ ও রসায়ন খাতের একটি কোম্পানি। সব মিলিয়ে কোম্পানিটির অবস্থা তুলনামূলক দুর্বল (আমাদের বিশ্লেষণে 100-এর মধ্যে 11)। কোম্পানিটি লাভজনক এবং গত বছরের তুলনায় এর মুনাফা বেড়েছে। একই ধরনের অন্যান্য কোম্পানির তুলনায় এই শেয়ারটির দাম এখন তুলনামূলক বেশি। কোম্পানিটি কিছুটা ডিভিডেন্ড দেয় (বছরে প্রায় 0.5%)।
এটি শিক্ষামূলক তথ্য, বিনিয়োগ পরামর্শ নয়।
Risky
AvoidWeak company, quiet trading
Five quick checks that tell you whether this company is healthy, fairly priced, and worth holding.
Looks pricey right now — costs more than usual for what you get.
P/E Ratio
4274.0
Price per ৳1 of yearly earnings
Dividend Yield
0.50%
Annual cash return on the price
P/B Ratio
0.5
Price per ৳1 of net assets
Trading at 4274.0 — above its 5-year average of 1416.5.
The raw figures behind the verdict — for the curious.
EPS
৳0.15
Earnings per share (latest year)
P/E Ratio
4487.0
Price you pay per ৳1 of earnings
Dividend Yield
0.50%
Annual cash return on the price
Reserve & Surplus
৳187 Cr
Company's accumulated savings
Total Loan
৳82.1 Cr
Outstanding debt the company carries
Are they making money — and do they share it with shareholders?
Yearly Profit
Net profit per year
Profitable in 4 out of the last 5 years.
Earnings Per Share
Profit you earn per share
Each share earned ৳0.1 in the latest year.
Yearly Cash Dividend
% of face value
Paid a dividend every year for 3 years running.
The deeper numbers — revenue, margins, debt and cash quality over the years.
What the share price has been doing over the last week.
Down 0.9% in the past week, lagging the overall market, on lighter-than-usual trading.
Past week
-0.9%
Price move over 7 days
Vs market
-1.6%
Ahead/behind the DSEX index
Trading volume
0.5×
vs its normal volume
Up days
2/7
Green days this week
52-week spot
33%
Position in 1-year range
Trades around ৳0.33 Cr a day on average over the past week.
The good signs and the things to keep an eye on.
Good signs
Watch-outs
LIBRAINFU scores below the other strong names in its sector shown here.
| Stock | ||||||
|---|---|---|---|---|---|---|
| MARICO | 84 | ৳2,731 | +0.1% | 14.6 | +14.1% | +78.4% |
| SQURPHARMA | 82 | ৳221 | -0.8% | 8.2 | +5.4% | +14.8% |
| KOHINOOR | 78 | ৳513 | +0.9% | 30.1 | +1.3% | +26.2% |
| RECKITTBEN | 74 | ৳3,326 | +0.2% | 19.2 | +5.2% | +45.4% |
| ACMELAB | 73 | ৳84.5 | +0.4% | 7.4 | +4.1% | +9.1% |
| LIBRAINFU | 11 | ৳641 | +0.2% | 4274.0 | +0.5% | +0.0% |
Who's behind this company — and how committed are they? As of Nov 2024, compared with Jun 2021.
Worth watching — big institutions cut their stake from 6.0% to 4.3% since Jun 2021. Keep an eye on why.
Owners (sponsors) hold 34% — a strong sign of commitment.
Recent news and announcements about this company.